Showing results (1-10 of 2,269) with videos related to
Sort By:
Pageof 227
The Journal of Biological Chemistry|May 25, 1989
Thyroid hormones inhibit platelet function and myosin light chain kinaseS Mamiya, M Hagiwara, S Inoue, et al.The Journal of Biological Chemistry|January 5, 1989
Selective binding of L-thyroxine by myosin light chain kinaseM Hagiwara, S Mamiya, H HidakaThrombosis Research|June 1, 1989
Specific inhibition of 40 K protein phosphorylation in platelet by a new antithrombotic agent, d-indobufenS Mamiya, M Hagiwara, T Ishikawa, et al.Biochemical and Biophysical Research Communications|April 15, 1988
Thyroid hormones inhibit the Ca2+ calmodulin-induced activation of myosin light chain kinaseM Hagiwara, S Mamiya, M Ochiai, et al.Molecular Pharmacology|June 1, 1989
Thyroid hormones directly interact with vascular smooth muscle stripsT Ishikawa, T Chijiwa, M Hagiwara, et al.Molecular Pharmacology|June 1, 1988
ML-9 inhibits the vascular contraction via the inhibition of myosin light chain phosphorylationT Ishikawa, T Chijiwa, M Hagiwara, et al.Biochemical Pharmacology|August 1, 1988
Differential effects of flavonoids as inhibitors of tyrosine protein kinases and serine/threonine protein kinasesM Hagiwara, S Inoue, T Tanaka, et al.Thrombosis Research|July 15, 1990
d-Indobufen inhibits collagen-induced intracellular calcium mobilization and inositol phosphates formation in human plateletsM Sumi, M Hagiwara, H HidakaBiochemical Pharmacology|February 1, 1984
Effects of vinpocetine on cyclic nucleotide metabolism in vascular smooth muscleM Hagiwara, T Endo, H HidakaNihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|October 1, 1982
[Effect of vinpocetine (TCV-3B), a vasodilator agent, on cyclic nucleotide metabolism]M Hagiwara, T Endo, H HidakaPageof 227